Science to Consumers Inc (CE) (BEUT) Share Price

Nice BEUT Reinstatement

Reinstatement hit EOM

Some may have to get out and push

from here over the next

hill ahead...


so we watch...LJ

Never seen a tiny float get flipped

so much like BEUT today...


https://www.otcmarkets.com/stock/BEUT/security


I want to know what sellers

are going to buy...


It must be extra special...


so we watch...LJ

$BEUT: AFter that 7:1 split........ 8.85Milly Float


is just Stupidly lowwwwwwwwwwwwwww.


Looking super solid all the way up to $1 from here.

Lets see the RM come in now



GO $BEUT

$BEUT: Letssss rolllllll......... Clear to $0.30





GO $BEUT

Custo granted

custo granted

Should we wear a tie on Thursday, since

it is custody court date?...


lol, seems easy if it changes

my bad luck streak...


so we watch...LJ

Found this doing custo research. it's #3 out of the one's that I found. Hopefully new owners can get some of the outstanding debt reduced.
Buying at gap close levels.

.0251 - 32M - Bryan Glass - hearing 8/12 {glad if changed to 8/5}
https://www.otcmarkets.com/stock/BEUT/security

150K Warrants 80K conv
https://www.otcmarkets.com/filing/conv_pdf?id=12180806&guid=jkvkkajPKBJ4f3h


https://www.barchart.com/stocks/quotes/BEUT/interactive-chart
Buy at .0200 final gap close at .004

GLTA

Custodianship court date moved up from 8/12 to 8/5 today

$BEUT: There you have it.... CustodianShip, GOOOOOOOOOOO


https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=FoURv98y2Fixrm6Br-RxAA2&tabIndex=3


Incredibly clean SS, no dilution, no issues....... big time upside coming.


Rolllll baby.......... nothing in your way and no one even knows yet


Going to $1


GO $BEUT

$BEUT : Chinese Beauty............... big opportunity


https://pitchbook.com/profiles/company/62779-78#stock



Science to Consumers, Inc. is a development-stage company. The Company is focused on distribution of Argan oil and Argan oil products to stores, spas, massage therapy offices and individuals in Germany. The Company is focused on marketing and selling DermLastyl skin care products. The Company sells approximately six products that are available to be purchased through its Website and wholesale orders. The Company sells various products, which include Dermalastyl Facial Scrub, Dermalastyl Bx Pro, Dermalastyl Bx Elastropin, Dermalastyl-e Intensive Eye Serum, Dermalastyl-m Wrinkle Eye Radicator, Dermalastyl-m Anti- Wrinkle after shave for Men. The Company is focused on marketing its products in China and its activities are divided into two segments, which include China activities and Hong Kong activities. As of May 31, 2016, the Company had not generated any revenues.
Company Contact

Headquarters

Room 1618
American Bank Centre, 555 Ren Min Road
04159 Guangzhou
CHN



GO $BEUT

$BEUT: $0.06 going here......... volume is up


Looking good for a $TZPC type run




GO $BEUT

Was there news Friday? Caught my attention

Took a few today.

long-term stock account scan BEUT bullish 0.75

normal chart


log chart

Last post 2 years ago WOW? DSR/dailystockreport.com promo this week had a bounce yesterday but today @year lows of .15, promo talks about the baby boomer ant-aging market potential and products that WILL BE marketed, have allegedly completely clinical trials --
but has this company ever actually marketed anything?

There is no official "news," on the brokerage website/PR Newswire etc.

Is this a "share selling scam" full of broken promises hence this silence, or what?

Kinda tempting to get in on the bottom unless this is the latter...

LOW volume can mean those in the know won't touch it again OR it can run on low volume -- HELLO? EARTH TO MARS?
ANYONE OUT THERE ON EARTH?

Gee thanks for camping out on the daily list.

Argan Beauty Corp., ABXX, changed to Science To Consumers Inc., BEUT:

http://otce.finra.org/DailyList

ABXX 7 for one forward split:

http://www.otcbb.com/asp/dailylist_detail.asp?d=08/18/2014&mkt_ctg=OTCBB

OK here I am. Let's light this candle.

Stock Split Filing on NVSOS and 8K's

Upon effect of the forward split, our authorized capital will increase from 75,000,000 shares of common stock to 525,000,000 shares of common stock and correspondingly, our issued and outstanding shares of common stock will increase from 4,250,000 to 29,750,000 shares of common stock, all with a par value of $0.001.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10139249

Previous Stock Value:
Par Value Shares: 75,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 75,000.00

New Stock Value:
Par Value Shares: 525,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 525,000.00
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=awQd4ZhBS5iI4ychwZi6qg%253d%253d&CorpName=ARGAN+BEAUTY+CORP.

Company Website might come up here: http://arganbeautycorp.com
Domain Name: ARGANBEAUTYCORP.COM
Registrar URL: http://www.godaddy.com
Registrant Name: Vitaliy Gorelik
Registrant Organization:
Name Server: NS53.DOMAINCONTROL.COM
Name Server: NS54.DOMAINCONTROL.COM
DNSSEC: unsigned

New CEO added too:
Burt Ensley, Ph.D. – Chief Executive Officer

Burt Ensley, Ph.D., is the founder of Protein Genomics, Inc. and DermaPlus, Inc., Arizona-based biotechnology companies involved in wound healing, tissue regeneration and skin care.

His professional career began in 1981 when he was hired by Amgen, Inc., a start-up biotech firm in Thousand Oaks, California, that he helped become the largest such company in the world within 10 years. Amgen now has 40,000 employees and $12 billion in annual revenue.

2

In 1989, Dr. Ensley left Amgen to serve as director of advanced technologies for Envirogen, Inc. There, he led research and field demonstrations of biological and physical/chemical technologies for the treatment of hazardous wastes from the company’s inception until its public offering in 1992. He then became a founder and the president, chief executive officer and director of Phytotech, Inc., a biotechnology company using plants for the treatment of contaminated soil and water. He raised financing for Phytotech of $5 million in equity and $2 million in debt from inception to sale of the business in June 1999.

In 1999, Dr. Ensley founded Nucycle Therapy, Inc., a biotechnology company involved in discovering, developing and commercializing unique nutritional supplements and high value nutraceutical and therapeutic products from plants. He served as the company’s chief executive officer from 1999 to 2001. The company was able to scale-up the manufacture of 50 million doses of plant-based nutritional mineral supplements, and was sold to Integrated Biopharma, a publicly traded entity, in 2001.

In 2004, Dr. Ensley founded Protein Genomics, Inc., a privately held genomics-based biopolymer company. The company designs and manufactures protein monomers and polymers of human structural molecules with applications in wound healing, tissue repair and personal care products. These products are designed directly from the mRNA sequences of individuals and population groups. Dr. Ensley currently acts as chairman and chief executive officer of Protein Genomics, Inc.

Dr. Ensley was elected to Fellowship in the American Academy of Microbiology in recognition of his research accomplishments. His professional affiliations have included membership in the board of directors and co-chair of The BIO5 Institute at the University of Arizona; board of trustees at the Biotechnology Council of New Jersey; board of directors of the Natural History Museum at the University of Kansas; the American Association for the Advancement of Science; the American Society for Microbiology; service on the National Research Council Committee on Catalysis; and on the biology directorate advisory committee of the National Science Foundation. He is an adjunct professor at Northern Arizona University.

He holds his Ph.D. degree in microbiology from the University of Georgia (1979), his master’s degree in biology from the University of New Mexico (1976), and bachelor’s degree in biology from the University of New Mexico (1974).

Dr. Ensley has 30 publications in peer-reviewed scientific literature and holds 19 issued and 2 pending US patents.

Dr. Ensley served in the US Army from August 1968 until May, 1971, graduating from the MACV Recondo School and serving with the 5th Special Forces Group, 1st Special Forces (Airborne) in Nha Trang, Vietnam. He was decorated twice (BSM and ARCOM) for service in combat.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10138271

second!

Marked Business Description